Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia

The genome of severe acute respiratory coronavirus-2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has undergone a rapid evolution, resulting in the emergence of multiple SARS-CoV-2 variants with amino acid changes. This study aimed to sequence the whole genome of SARS...

Full description

Bibliographic Details
Main Authors: Feda A. Alsuwairi, Asma N. Alsaleh, Dalia A. Obeid, Ahmed A. Al-Qahtani, Reem S. Almaghrabi, Basma M. Alahideb, Maha A. AlAbdulkareem, Madain S. Alsanea, Layla A. Alharbi, Sahar I. Althawadi, Sara A. Altamimi, Abeer N. Alshukairi, Fatimah S. Alhamlan
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/12/3/467
_version_ 1797239990266101760
author Feda A. Alsuwairi
Asma N. Alsaleh
Dalia A. Obeid
Ahmed A. Al-Qahtani
Reem S. Almaghrabi
Basma M. Alahideb
Maha A. AlAbdulkareem
Madain S. Alsanea
Layla A. Alharbi
Sahar I. Althawadi
Sara A. Altamimi
Abeer N. Alshukairi
Fatimah S. Alhamlan
author_facet Feda A. Alsuwairi
Asma N. Alsaleh
Dalia A. Obeid
Ahmed A. Al-Qahtani
Reem S. Almaghrabi
Basma M. Alahideb
Maha A. AlAbdulkareem
Madain S. Alsanea
Layla A. Alharbi
Sahar I. Althawadi
Sara A. Altamimi
Abeer N. Alshukairi
Fatimah S. Alhamlan
author_sort Feda A. Alsuwairi
collection DOAJ
description The genome of severe acute respiratory coronavirus-2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has undergone a rapid evolution, resulting in the emergence of multiple SARS-CoV-2 variants with amino acid changes. This study aimed to sequence the whole genome of SARS-CoV-2 and detect the variants present in specimens from Saudi Arabia. Furthermore, we sought to analyze and characterize the amino acid changes in the various proteins of the identified SARS-CoV-2 variants. A total of 1161 samples from patients diagnosed with COVID-19 in Saudi Arabia, between 1 April 2021 and 31 July 2023, were analyzed. Whole genome sequencing was employed for variant identification and mutation analysis. The statistical analysis was performed using the Statistical Analytical Software SAS, version 9.4, and GraphPad, version 9.0. This study identified twenty-three variants and subvariants of SARS-CoV-2 within the population, with the Omicron BA.1 (21K) variant (37.0%) and the Delta (21J) variant (12%) being the most frequently detected. Notably, the Omicron subvariants exhibited a higher mean mutation rate. Amino acid mutations were observed in twelve proteins. Among these, the spike (S), ORF1a, nucleocapsid (N), and ORF1b proteins showed a higher frequency of amino acid mutations compared to other the viral proteins. The S protein exhibited the highest incidence of amino acid mutations (47.6%). Conversely, the ORF3a, ORF8, ORF7a, ORF6, and ORF7b proteins appeared more conserved, demonstrating the lowest percentage and frequency of amino acid mutations. The investigation of structural protein regions revealed the N-terminal S1 subunit of the S protein to frequently harbor mutations, while the N-terminal domain of the envelope (E) protein displayed the lowest mutation frequency. This study provides insights into the variants and genetic diversity of SARS-CoV-2, underscoring the need for further research to comprehend its genome evolution and the occurrence of mutations. These findings are pertinent to the development of testing approaches, therapeutics, and vaccine strategies.
first_indexed 2024-04-24T18:00:19Z
format Article
id doaj.art-45818b16583a49e29bb1b1ab96c2fb49
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-04-24T18:00:19Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-45818b16583a49e29bb1b1ab96c2fb492024-03-27T13:55:33ZengMDPI AGMicroorganisms2076-26072024-02-0112346710.3390/microorganisms12030467Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi ArabiaFeda A. Alsuwairi0Asma N. Alsaleh1Dalia A. Obeid2Ahmed A. Al-Qahtani3Reem S. Almaghrabi4Basma M. Alahideb5Maha A. AlAbdulkareem6Madain S. Alsanea7Layla A. Alharbi8Sahar I. Althawadi9Sara A. Altamimi10Abeer N. Alshukairi11Fatimah S. Alhamlan12Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaBotany and Microbiology Department, College of Science, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaOrgan Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaDepartment of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaCollege of Medicine, Alfaisal University, Riyadh 11533, Saudi ArabiaDepartment of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi ArabiaThe genome of severe acute respiratory coronavirus-2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has undergone a rapid evolution, resulting in the emergence of multiple SARS-CoV-2 variants with amino acid changes. This study aimed to sequence the whole genome of SARS-CoV-2 and detect the variants present in specimens from Saudi Arabia. Furthermore, we sought to analyze and characterize the amino acid changes in the various proteins of the identified SARS-CoV-2 variants. A total of 1161 samples from patients diagnosed with COVID-19 in Saudi Arabia, between 1 April 2021 and 31 July 2023, were analyzed. Whole genome sequencing was employed for variant identification and mutation analysis. The statistical analysis was performed using the Statistical Analytical Software SAS, version 9.4, and GraphPad, version 9.0. This study identified twenty-three variants and subvariants of SARS-CoV-2 within the population, with the Omicron BA.1 (21K) variant (37.0%) and the Delta (21J) variant (12%) being the most frequently detected. Notably, the Omicron subvariants exhibited a higher mean mutation rate. Amino acid mutations were observed in twelve proteins. Among these, the spike (S), ORF1a, nucleocapsid (N), and ORF1b proteins showed a higher frequency of amino acid mutations compared to other the viral proteins. The S protein exhibited the highest incidence of amino acid mutations (47.6%). Conversely, the ORF3a, ORF8, ORF7a, ORF6, and ORF7b proteins appeared more conserved, demonstrating the lowest percentage and frequency of amino acid mutations. The investigation of structural protein regions revealed the N-terminal S1 subunit of the S protein to frequently harbor mutations, while the N-terminal domain of the envelope (E) protein displayed the lowest mutation frequency. This study provides insights into the variants and genetic diversity of SARS-CoV-2, underscoring the need for further research to comprehend its genome evolution and the occurrence of mutations. These findings are pertinent to the development of testing approaches, therapeutics, and vaccine strategies.https://www.mdpi.com/2076-2607/12/3/467COVID-19SARS-CoV-2genomevariantsamino acidmutations
spellingShingle Feda A. Alsuwairi
Asma N. Alsaleh
Dalia A. Obeid
Ahmed A. Al-Qahtani
Reem S. Almaghrabi
Basma M. Alahideb
Maha A. AlAbdulkareem
Madain S. Alsanea
Layla A. Alharbi
Sahar I. Althawadi
Sara A. Altamimi
Abeer N. Alshukairi
Fatimah S. Alhamlan
Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
Microorganisms
COVID-19
SARS-CoV-2
genome
variants
amino acid
mutations
title Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
title_full Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
title_fullStr Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
title_full_unstemmed Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
title_short Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia
title_sort genomic surveillance and mutation analysis of sars cov 2 variants among patients in saudi arabia
topic COVID-19
SARS-CoV-2
genome
variants
amino acid
mutations
url https://www.mdpi.com/2076-2607/12/3/467
work_keys_str_mv AT fedaaalsuwairi genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT asmanalsaleh genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT daliaaobeid genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT ahmedaalqahtani genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT reemsalmaghrabi genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT basmamalahideb genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT mahaaalabdulkareem genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT madainsalsanea genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT laylaaalharbi genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT saharialthawadi genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT saraaaltamimi genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT abeernalshukairi genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia
AT fatimahsalhamlan genomicsurveillanceandmutationanalysisofsarscov2variantsamongpatientsinsaudiarabia